Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class

被引：0
|
作者：
Buchdunger, E.
Zimmermann, J.
Mett, H.
Meyer, T.
机构：
来源：
Physical Review B: Condensed Matter | 1995年 / 51卷 / 24期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] SELECTIVE-INHIBITION OF THE PLATELET-DERIVED GROWTH-FACTOR SIGNAL-TRANSDUCTION PATHWAY BY A PROTEIN-TYROSINE KINASE INHIBITOR OF THE 2-PHENYLAMINOPYRIMIDINE CLASS
    BUCHDUNGER, E
    ZIMMERMANN, J
    METT, H
    MEYER, T
    MULLER, M
    REGENASS, U
    LYDON, NB
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (07) : 2558 - 2562
  • [2] Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class (vol 92, pg 2558, 1995)
    Buchdunger, E
    Zimmermann, J
    Mett, H
    Meyer, T
    Müller, M
    Regenass, U
    Lydon, NB
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) : 12069 - 12069
  • [3] Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class
    Kilic, T
    Alberta, JA
    Zdunek, PR
    Acar, M
    Iannarelli, P
    O'Reilly, T
    Buchdunger, E
    Black, PM
    Stiles, CD
    CANCER RESEARCH, 2000, 60 (18) : 5143 - 5150
  • [4] SELECTIVE-INHIBITION OF THE PLATELET-DERIVED GROWTH-FACTOR SIGNAL-TRANSDUCTION PATHWAY BY A NOVEL TYROSINE PROTEIN-KINASE INHIBITOR OF THE 2-PHENYLAMINO PYRIMIDINE CLASS
    LYDON, NB
    ZIMMERMANN, J
    METT, H
    MEYER, T
    MULLER, M
    REGENASS, U
    BUCHDUNGER, E
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 69 - 69
  • [5] Inhibition of obliterative bronchiolitis by platelet-derived growth factor receptor protein-tyrosine kinase inhibitor
    Kallio, E
    Koskinen, P
    Buchdunger, E
    Lemström, K
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 187 - 187
  • [6] Inhibition of the abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative
    Buchdunger, E
    Zimmermann, J
    Mett, H
    Meyer, T
    Muller, M
    Druker, BJ
    Lydon, NB
    CANCER RESEARCH, 1996, 56 (01) : 100 - 104
  • [7] Prevention of cardiac allograft arteriosclerosis by protein-tyrosine kinase inhibitor selective for platelet-derived growth factor receptor
    Koskinen, P
    Sihvola, R
    Myllärniemi, M
    Häyry, P
    Buchdunger, E
    Lemström, K
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 102 - 102
  • [8] Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-Kit and platelet-derived growth factor receptors
    Buchdunger, E
    Cioffi, CL
    Law, N
    Stover, D
    Ohno-Jones, S
    Druker, BJ
    Lydon, NB
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 295 (01): : 139 - 145
  • [9] Prevention of cardiac allograft arteriosclerosis by protein tyrosine kinase inhibitor selective for platelet-derived growth factor receptor
    Sihvola, R
    Koskinen, P
    Myllärniemi, M
    Loubtchenkov, M
    Häyry, P
    Buchdunger, E
    Lemström, K
    CIRCULATION, 1999, 99 (17) : 2295 - 2301
  • [10] A potent inhibitor of platelet-derived growth factor receptor tyrosine kinase
    Min, DS
    Lee, YH
    Kang, LW
    Byoun, CH
    Chang, JS
    Ryn, SH
    Suh, PG
    MOLECULES AND CELLS, 1996, 6 (04) : 463 - 468
12345